The Molecular Targets for the Diagnosis and Treatment of Pancreatic Cancer

Pancreatic cancer is considered an aggressive malignancy that responds poorly to current treatments and therefore has a dismal survival rate. This disease is usually not diagnosed until a late stage, at which point palliative chemotherapy with the purine analogue gemcitabine and/or a fluoropyrimidin...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Strimpakos, Alexios S., Syrigos, Kostas N., Saif, Muhammad Wasif
Médium: Artigo
Jazyk:Inglês
Vydáno: The Korean Society of Gastroenterology; the Korean Society of Gastrointestinal Endoscopy; the Korean Association for the Study of the Liver; the Korean Society of Neurogastroenterology and Motility; Korean Association for the Study of Intestinal Diseases; Korean College of Helicobacter and Upper Gastrointestinal Research; Korean Society of Pancreatobiliary Diseases 2010
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3021599/
https://ncbi.nlm.nih.gov/pubmed/21253292
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl.2010.4.4.433
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky